Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire ARZ
View:
Post by TaaHou on Nov 29, 2018 9:56am

Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire ARZ

https://www.newswire.ca/news-releases/nuvo-pharmaceuticals-declared-winning-bidder-to-acquire-commercial-products-from-aralez-pharmaceuticals-701535811.html


does this mean anything good if im stuck on .50
Comment by rxq1212 on Dec 03, 2018 11:39pm
At least mean the sale of the 2 major brands is going..1 down/ waiting for the other one..cant remenber but think both were in the order of $240M usd...checking with the lawyer/monitor said the liquidation process will continue for a few months...so all can do i wait and hope they are able to sell all...there is $280M usd in creditors ahead of stockholders per a report from the monitor...unsure ...more  
Comment by Tissue4Tears on Dec 11, 2018 8:45pm
Dude, it's finished. It's been finished for months. Finito. $0. Done. 
Comment by rxq1212 on Jan 09, 2019 3:45pm
You could be right.. time will tell. Below response from the lawyer looking after the CCAA process for Aralez " Dear Sir, The shares of Aralez Pharmaceuticals Canada Inc (APCI), a subsidiary of Aralez Pharmaceuticals Inc (API), were sold to Nuvo Pharmaceuticals. The transaction closed on December 31, 2018. Upon closing of the transaction, the CCAA proceedings with respect to APCI were ...more  
Old API Wind-down Ltd - Ordinary Shares
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities